Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H58N2O3 |
| Molecular Weight | 530.8252 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 12 |
| E/Z Centers | 0 |
| Charge | 2 |
SHOW SMILES / InChI
SMILES
CC(=O)O[C@H]1C[C@@H]2CC[C@H]3[C@@H]4C[C@@H]([C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)C[C@@H]1[N+]5(C)CCCCC5)[N+]6(C)CCCCC6
InChI
InChIKey=XQFBAGUGBNQLRT-ZZZJANDJSA-N
InChI=1S/C33H58N2O3/c1-23(36)38-30-20-24-12-13-25-26(33(24,3)22-29(30)35(5)18-10-7-11-19-35)14-15-32(2)27(25)21-28(31(32)37)34(4)16-8-6-9-17-34/h24-31,37H,6-22H2,1-5H3/q+2/t24-,25+,26-,27-,28-,29-,30-,31-,32-,33-/m0/s1
| Molecular Formula | C33H57N2O3 |
| Molecular Weight | 529.8173 |
| Charge | 1 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 12 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Dacuronium is an aminosteroid, acting as a competitive antagonist of nicotinic acetylcholine receptors. In animals, dacuronium worked as a short-acting muscle relaxant with a rapid onset of action. In a clinical trial, dacuronium was markedly less potent than tubocurarine and did not show a rapid recovery from its action.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:30:15 GMT 2025
by
admin
on
Mon Mar 31 18:30:15 GMT 2025
|
| Record UNII |
VD6L56ZVX1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1494240
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY | |||
|
43021-45-0
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY | |||
|
VD6L56ZVX1
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY | |||
|
C003549
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY | |||
|
Dacuronium
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY | |||
|
218421
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY | |||
|
C83646
Created by
admin on Mon Mar 31 18:30:15 GMT 2025 , Edited by admin on Mon Mar 31 18:30:15 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE LESS ACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |